Nucleus raphe dorsalis in Alzheimer's disease: Neurofibrillary tangles and loss of large neurons
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Diffuse serotonergic fibers are presumed to project to the talencephalon from the nucleus raphe dorsalis (NRD) of the mid brain, in a manner similiar to the cholinergic projections from the nucleus basalis of Meynert (nbM) to the cerebral cortex. Neuropathological changes in both of these nuclei have been reported in Alzheimer's disease (AD). Although many morphometric studies of the nbM in AD have been documented, only one such study of the NRD has been documented, only one such study of the NRD has been conducted so far; it demonstrated a six fold increase in neurofibrillary tangles in AD but no statistically significant difference in the number of neurons in patients with AD and age‐matched controls. A study of the NRD utilizing different stains and wider anatomical boundaries is detailed in this report of 5 patients with AD and 7 age‐matched controls. In AD the NRD showed 39 times more neurofibrillary tangles and the number and cell density of large neurons were reduced to 23% and 28%, respectively, of those in the controls. A small number of senile plaques were found in the NRD in all patients with AD but none were found in the controls.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Arendt, T., Bigl, V., Arendt, A., & Tennstedt, A. (1983) · Acta Neuropathologica · doi:10.1007/bf00697388 · Cited by 817
Basal forebrain neurons in the dementia of Parkinson disease
Whitehouse, P. J., Hedreen, J. C., White, C. L., & Price, D. L. (1983) · Annals of Neurology · doi:10.1002/ana.410130304 · Cited by 534
Changes in the Brain Catecholamines in Patients with Dementia of Alzheimer Type
Adolfsson, R., Gottfries, C. G., Roos, B. E., & Winblad, B. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.135.3.216 · Cited by 449
Bowen, D. M., Allen, S. J., Benton, J. S., Goodhardt, M. J., Haan, E. A., Palmer, A. M., Sims, N. R., Smith, C. C. T., Spillane, J. A., Esiri, M. M., et al. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb11838.x · Cited by 443
Jones, E. G., Burton, H., Saper, C. B., & Swanson, L. W. (1976) · Journal of Comparative Neurology · doi:10.1002/cne.901670402 · Cited by 420
Alzheimer's Neurofibrillary Changes: A Topographic Study
HIRANO, A. (1962) · Archives of Neurology · doi:10.1001/archneur.1962.04210030065009 · Cited by 402
Self-citationDescarries, L., Watkins, K. C., Garcia, S., & Beaudet, A. (1982) · Journal of Comparative Neurology · doi:10.1002/cne.902070305 · Cited by 380
Ishii, T. (1966) · Acta Neuropathologica · doi:10.1007/bf00686763 · Cited by 303
CURCIO, C. A., & KEMPER, T. (1984) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198407000-00001 · Cited by 225
Cited by
A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat
Vertes, R. P. (1991) · Journal of Comparative Neurology · doi:10.1002/cne.903130409 · Cited by 842
Katzman, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604103141506 · Cited by 801
Neuron numbers and dendritic extent in normal aging and Alzheimer’s disease
Coleman, P. D., & Flood, D. G. (1987) · Neurobiology of Aging · doi:10.1016/0197-4580(87)90127-8 · Cited by 772
Uchida, Y., Takio, K., Titani, K., Ihara, Y., & Tomonaga, M. (1991) · Neuron · doi:10.1016/0896-6273(91)90272-2 · Cited by 699
Davies, C. A., Mann, D. M. A., Sumpter, P. Q., & Yates, P. O. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90057-8 · Cited by 628
The neuropathology of aminergic nuclei in Alzheimer's disease
Zweig, R. M., Ross, C. A., Hedreen, J. C., Steele, C., Cardillo, J. E., Whitehouse, P. J., Folstein, M. F., & Price, D. L. (1988) · Annals of Neurology · doi:10.1002/ana.410240210 · Cited by 446
Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease
Halliday, G. M., Li, Y. W., Blumbergs, P. C., Joh, T. H., Cotton, R. G. H., Howe, P. R. C., Blessing, W. W., & Geffen, L. B. (1990) · Annals of Neurology · doi:10.1002/ana.410270405 · Cited by 408
Jellinger, K. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.4.540 · Cited by 373
The car☐yl third of tau is tightly bound to paired helical filaments
Kondo, J., Honda, T., Mori, H., Hamada, Y., Miura, R., Ogawara, M., & Ihara, Y. (1988) · Neuron · doi:10.1016/0896-6273(88)90130-4 · Cited by 355
YAMAMOTO, T., & HIRANO, A. (1986) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1986.tb00677.x · Cited by 327
Self-citationArendt, T., Schindler, C., Brückner, M. K., Eschrich, K., Bigl, V., Zedlick, D., & Marcova, L. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-02-00516.1997 · Cited by 319
“A severe neuronal degeneration was observed in the basal nucleus of Meynert, locus coeruleus, the median raphe nucleus, medial amygdaloid nucleus, pedunculopontine tegmental nucleus, and substantia nigra, thereby confirming a number of earlier studies (Herzog and Kemper, 1980; Arendt et al., 1983; Mann et al., 1983; S…”
ResultZubenko, G. S., Zubenko, W. N., McPherson, S., Spoor, E., Marin, D. B., Farlow, M. R., Smith, G. E., Geda, Y. E., Cummings, J. L., Petersen, R. C., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.5.857 · Cited by 314
Therapeutics of Neurotransmitters in Alzheimer’s Disease
Kandimalla, R., & Reddy, P. H. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161118 · Cited by 268
The serotonergic system in ageing and Alzheimer's disease
Rodríguez, J. J., Noristani, H. N., & Verkhratsky, A. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.010 · Cited by 264
Brain angiotensin receptor subtypes in the control of physiological and behavioral responses
Wright, J. W., & Harding, J. W. (1994) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)90034-5 · Cited by 263
The role of cortical connectivity in Alzheimer's disease pathogenesis: A review and model system
de LaCoste, M.-C., & White, C. L. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90015-4 · Cited by 253
Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis
Lyness, S. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00057-x · Cited by 240
“Although less well studied, loss of serotonergic, 5-hydroxytryptamine (5-HT), neurons has also been reported in AD [2,19,30,48,61,145,147,150].”
BackgroundQuantitation of cerebral atrophy in preclinical and end-stage Alzheimer’s disease
de la Monte, S. M. (1989) · Annals of Neurology · doi:10.1002/ana.410250506 · Cited by 229
Fetal‐Type Phosphorylation of the τ in Paired Helical Filaments
Kanemaru, K., Takio, K., Miura, R., Titani, K., & Ihara, Y. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10039.x · Cited by 219
Cell number changes in Alzheimer's disease relate to dementia, not to plaques and tangles
Andrade-Moraes, C. H., Oliveira-Pinto, A. V., Castro-Fonseca, E., da Silva, C. G., Guimaraes, D. M., Szczupak, D., Parente-Bruno, D. R., Carvalho, L. R. B., Polichiso, L., Gomes, B. V., et al. (2013) · Brain · doi:10.1093/brain/awt273 · Cited by 216
“…disease, some pathology studies have suggested that Alzheimer’s syndrome actually begins in the brainstem and dis-seminates throughout the brain (Yamamoto and Hirano, 1985; Hardy et al ., 1986; German et al ., 1987; Grinberg et al ., 2009; Simic et al ., 2009; Braak et al ., 2011; Grinberg et…”
Does Alzheimer's disease begin in the brainstem?
Simic, G., Stanic, G., Mladinov, M., Jovanov‐Milosevic, N., Kostovic, I., & Hof, P. R. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2009.01038.x · Cited by 204
“Hirano, 1985 [ 136 ] The goal was to determine the number of NFTs and neurones in the DRN in AD 5 7 Authors reported 72% decrease in DRN cell density and 77% loss of large neurones in AD patients as compared with controls Biased methodology of estimation of nerve cell loss and frequency of NFTs from densities assessed…”
Alzheimer's disease: Neurofibrillary tangles in nuclei that project to the cerebral cortex
German, D. C., White, C. L., & Sparkman, D. R. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90123-0 · Cited by 203
MICHELSEN, K., PRICKAERTS, J., & STEINBUSCH, H. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00912-6 · Cited by 196
“DRN neurons decrease in number in AD (Curcio and Kemper, 1984; Yamamoto and Hirano, 1985; Aletrino et al., 1992).”
BackgroundAltman, H. J., & Normile, H. J. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80124-6 · Cited by 181
The Neuroanatomy of Alzheimer's Disease
Pearson, R. C. A., & Powell, T. P. S. (1989) · Reviews in the Neurosciences · doi:10.1515/revneuro.1989.2.2.101 · Cited by 179
Cytoarchitecture of the human dorsal raphe nucleus
Baker, K. G., Halliday, G. M., & Törk, I. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.903010202 · Cited by 174
Histamine neurons in human hypothalamus: Anatomy in normal and alzheimer diseased brains
Alraksinen, M. S., Paetau, A., Palja¨rvi, L., Reinikainen, K., Rlekkinen, P., Suomalainen, R., & Panula, P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90070-5 · Cited by 163
Major depression, cognitive dysfunction and Alzheimer's disease: Is there a link?
Sierksma, A. S. R., van den Hove, D. L. A., Steinbusch, H. W. M., & Prickaerts, J. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.021 · Cited by 139
The substantia nigra and ventral tegmental area in Alzheimer’s disease and Down’s syndrome
Gibb, W. R., Mountjoy, C. Q., Mann, D. M., & Lees, A. J. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.2.193 · Cited by 122
Hendricksen, M., Thomas, A. J., Ferrier, I. N., Ince, P., & O’Brien, J. T. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1096 · Cited by 121
Alzheimer’s Disease: The Alternative Serotonergic Hypothesis of Cognitive Decline
Vakalopoulos, C. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-170364 · Cited by 34
Metadata
- Authors
- Yamamoto, T., & Hirano, A.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1985-06
- Volume
- 17
- Issue
- 6
- Pages
- 573-577
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2023055592
- Cited by
- 338
- References
- 21
- FWCI
- 23.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.